Details of the Drug Combinations

General Information of This Drug (ID: DM0GBB5)

Drug Name
PF-04634817   DM0GBB5
Indication
Disease Entry ICD 11 Status REF
Diabetic nephropathy GB61.Z Phase 2 [1]
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
PF-04634817 + Salicylhydroxamic acid DCFG1WJ Salicylhydroxamic acid Macular Edema, Diabetic [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01712061) A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01994291) A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema